4,217 Stroke Recovery Trials
Are Enrolling Right Now.
Catalyst matches stroke survivors to Phase II and Phase III recovery trials within 72 hours — by stroke subtype, location, and eligibility window.
of eligible survivors never learn a trial exists.
Most stroke patients are discharged with a standard rehab plan and no awareness of ongoing research. Catalyst closes this gap in the first 72 hours.
average time from inquiry to first trial match.
Traditional referral pathways take weeks. Our eligibility parsing engine works against a live database, returning ranked matches while the recovery window is still open.
strokes occur worldwide every year.
Two-thirds of survivors experience lasting functional or cognitive disability. Clinical trials represent the frontier of recovery science — and most never reach the people who need them most.
Three steps from discharge
to a matched trial.
Eligibility Parsing
You tell us your stroke subtype (ischemic, hemorrhagic, or TIA), weeks since event, and functional status. Catalyst maps this against the inclusion and exclusion criteria of every active Phase II and III trial in our database.
Proximity Matching
We filter by your zip code and willingness to travel — whether that's 10 miles or cross-country for a telerehabilitation protocol. NIH StrokeNet's 500+ recruitment sites are mapped in real time.
Ranked Match Report
Within 72 hours, you receive a ranked list of trials with contact information for site coordinators, plain-language summaries of what participation involves, and a shareable PDF for your neurologist.
Active trials,
updated daily.
Telerehabilitation for Post-Stroke Arm Recovery
Arm-function telerehabilitation added to usual care for patients with arm weakness. 70 min/day, 6 days/week for 6 weeks. Onset within 90–150 days.
High-Intensity Exercise for Post-Stroke Aphasia
Interval training program combining cardiovascular fitness with language therapy. Targets survivors with communication deficits from left-hemisphere stroke.
Treatment for Post-Stroke Spatial Inattention
Led by University of East Anglia across 8 major stroke centres. Targeting spatial inattention affecting 1 in 3 survivors — currently no approved treatment exists.
DM199 (Rinvecalinase Alfa) for Acute Ischemic Stroke
Evaluating DM199 in moderate severity ischemic stroke within 24 hours of onset. Focuses on small and medium vessel occlusions with limited treatment options.
Sleep Apnea PAP Therapy Post-Stroke
Positive airway pressure for obstructive sleep apnea starting shortly after acute ischemic stroke. Reduces recurrent stroke and all-cause mortality at 6 months.
Robotic Therapy for Subacute Motor Deficit
Upper-limb robotic rehabilitation during the subacute phase (strongest evidence window). Intervention duration >6 weeks, targeting survivors under 70 years.
"Three weeks out of the hospital, I was doing home PT and assuming that was it. Catalyst sent me a match for a robotic arm trial forty minutes from my house. I didn't know that was something I could even ask for."
Margaret T.
Ischemic stroke survivor, 67 · Columbus, OH
"My father couldn't speak after his stroke. I found this at midnight on a Tuesday. By Thursday morning I had a list of aphasia trials within driving distance. The site coordinator called him directly."
Daniel R.
Son and caregiver · Baltimore, MD
"I refer patients here now as a standard part of discharge planning. The eligibility matching is more current than anything I could pull manually from ClinicalTrials.gov."
Dr. Priya Nair, MD
Neurologist, Johns Hopkins Stroke Center
Send a clinical trial summary
to your patient's chart.
Enter your patient's stroke profile and we generate a shareable PDF — ranked matches, eligibility summaries, and site coordinator contacts — formatted for clinical handoff.
Also captures your email for follow-up match updates
Find matching trials
in 72 hours or less.
Three short steps. No medical records required.
Trials matching your profile
4,217 trials enrolling